References
- *Anonymous. Animal products notice: Specifications for animals treated with Buparvaquone. http://www.foodsafety.govt.nz/elibrary/industry/ap-notice-specs-for-animals-treated-with-boparvaquone.pdf (accessed 14 June 2016). Ministry for Primary Industries, Wellington, NZ, 2014
- *Bailey G. Buparvaquone tissue residue study. http://www.mla.com.au/Research-and-development/Search-R-D-reports/RD-report-details/R-and-D-Report-Download?itemId=123 (accessed 14 June 2016). Meat and Livestock Australia Limited, North Sydney, NSW, Australia, 2013
- Dolan TT. Chemotherapy of East Coast fever: the long term weight changes, carrier state and disease manifestations of parvaquone treated cattle. Journal of Comparative Pathology 96, 137–46, 1986 doi: 10.1016/0021-9975(86)90004-6
- Kinabo LDB, Bogan JA. Parvaquone and buparvaquone: HPLC analysis and comparative pharmacokinetics in cattle. Acta Tropica 45, 87–94, 1988
- Manzoori JL, Jouyban A, Amjadi M, Panahi-Azar V, Reza Karami-Bonarid A, Tamizie E. Spectrofluorimetric determination of buparvaquone in biological fluids, food samples and a pharmaceutical formulation by using terbium–deferasirox probe. Food Chemistry 126, 1845–9, 2011 doi: 10.1016/j.foodchem.2010.11.160
- Mbwambo HA, Magwisha HB, Mfinanga JM. Evaluation of buparvaquone (BUTA-Kel™ KELA, Belgium) as a treatment of East Coast fever in cattle, in the peri-urban of Dar Es Salaam City, Tanzania. Veterinary Parasitology 139, 67–73, 2006 doi: 10.1016/j.vetpar.2006.02.024
- McHardy N. Recent advances in the chemotherapy of theileriosis. Preventive Veterinary Medicine 2, 179–82, 1984 doi: 10.1016/0167-5877(84)90061-8
- *McHardy N. Butalex ( buparvaquone) - A new therapeutic for theileriosis. In: Dolan TT (ed). Recent Developments in the Research and Control of Theileria annulata. Pp 59–66. The International Laboratory for Research on Animal Disease, Nairobi, Kenya, 1992
- Muraguri GR, Kiara HK, McHardy N. Treatment of East Coast fever: a comparison of parvaquone and buparvaquone. Veterinary Parasitology 87, 25–37, 1999 doi: 10.1016/S0304-4017(99)00154-5
- Muraguri GR, Ngumi PN, Wesonga, D, Ndungu SG, Wanjohi JM, Bang K, Fox A, Dunne J, McHardy N. Clinical efficacy and plasma concentrations of two formulations of buparvaquone in cattle infected with East Coast fever (Theileria parva infection). Research in Veterinary Sciences 81, 119–26, 2006 doi: 10.1016/j.rvsc.2005.09.012
- Pulford DJ, McFadden AMJ, Hamilton JS, Donald J. Investigation of the index case herd and identification of the genotypes of Theileria orientalis associated with outbreaks of bovine anaemia in New Zealand in 2012. New Zealand Veterinary Journal 64, 21–8, 2016 doi: 10.1080/00480169.2015.1090355
- Venkatesh G, Majid MIA, Ramanathan S, Mansor SM, Nair NK, Sattar MA. Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: A tool for the standardization of rat in situ intestinal permeability studies. Journal of Pharmaceutical and Biomedical Analysis 43, 1546–51, 2007 doi: 10.1016/j.jpba.2006.11.013
- Vink WD, Lawrence K, McFadden AMJ, Bingham P. An assessment of the herd-level impact of the Theileria orientalis (Ikeda) epidemic of cattle in New Zealand, 2012–2013: A mixed methods approach. New Zealand Veterinary Journal 64, 48–54, 2016 doi: 10.1080/00480169.2015.1090893